Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Wen-qi Jiang"'
Autor:
Hai‐Xia He, Yan Gao, Bing Bai, Xiao‐Xiao Wang, Ji‐Bin Li, Cheng Huang, Jia‐Ying Mao, Li‐Qin Ping, Qi‐Xiang Rong, Yan‐Xia He, He Huang, Qing‐Qing Cai, Zhi‐Ming Li, Wen‐Qi Jiang, Hui‐Qiang Huang
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7650-7664 (2021)
Abstract Purpose Some studies have indicated that using 500 mg/m2 rituximab combined with CHOP‐14 may be beneficial for elderly men but not women with diffuse large B‐cell lymphoma (DLBCL). The purpose of this study was to investigate the potenti
Externí odkaz:
https://doaj.org/article/a921548233734c3d8c5113b7e54a90cf
Autor:
Meng Li, Steven P. Sylvester, Zhang-Pei Wang, Yi-Da Pei, Xin-Fen Gao, Yuan Zhao, Wen-Qi Jiang
Publikováno v:
PhytoKeys, Vol 166, Iss , Pp 29-39 (2020)
Sorbus harrowiana (≡Pyrus harrowiana), previously considered a synonym of Sorbus insignis (≡Pyrus insignis) in the Flora of China, is re-instated here and shown to be distinct from S. insignis, based on morphometric analysis, coupled with herbari
Externí odkaz:
https://doaj.org/article/b8b21bc1b5e2469fb8656cd3f3bc274d
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Triple-negative breast cancer (TNBC) patients have relatively poor clinical outcomes. A marker predicting the prognosis of patients with TNBC could help guide treatment. Extensive evidence demonstrates that angiopoietin-like 4 (AN
Externí odkaz:
https://doaj.org/article/e2da19570c884ee799fc0d1036b85c47
Autor:
Yu Wang, Cai-Qin Wang, Peng Sun, Pan-Pan Liu, Hang Yang, Han-Yu Wang, Hui-Lan Rao, Su Li, Wen-Qi Jiang, Jia-Jia Huang, Zhi-Ming Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Patients with extranodal natural killer/T-cell lymphoma (ENKTL), nasal type are benefit from peg-asparaginase, gemcitabine, and methotrexate. Therefore, we conducted a prospective phase II trial using a combination of these drugs as GAD-M regimen in
Externí odkaz:
https://doaj.org/article/319a0f8bfe754136941c20ecea6e94ba
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background Bcl-2 family members play an important role in the development of malignant lymphoma and can induce drug resistance in anticancer treatment. The development of small molecules targeting Bcl-2 family proteins may be a new strategy
Externí odkaz:
https://doaj.org/article/408bc3743c7b47b39f3819f51dce8889
Autor:
Ke Wu, Xiao‐Qing Sun, Cai‐Qin Wang, Tian‐Xiao Gao, Peng Sun, Yu Wang, Wen‐Qi Jiang, Zhi‐Ming Li, Jia‐Jia Huang
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4688-4698 (2019)
Abstract Patients with Non‐Hodgkin lymphoma (NHL) treated by conventional chemotherapeutic drugs usually require a long recovery period. However, metronomic combination chemotherapy (MCC) enhances therapeutic efficacy and decreases side effects in
Externí odkaz:
https://doaj.org/article/6e7ba7e9621049d0b5f558f03e4fd1ba
Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma
Autor:
Xue-wen Zhang, Xi-wen Bi, Pan-pan Liu, Ze-long Liu, Man Nie, Hang Yang, De-xin Lei, Yi Xia, Wen-qi Jiang, Wei-an Zeng
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Natural killer/T-cell lymphoma (NKTCL) is a highly aggressive lymphoma with a dismal prognosis, and novel therapeutic targets are urgently needed. Programmed death-ligand 1 (PD-L1) has become a promising therapeutic target for various can
Externí odkaz:
https://doaj.org/article/214067872a314b7da2c130f57eea120f
Autor:
Pan‐pan Liu, Ke‐feng Wang, Jie‐tian Jin, Xi‐wen Bi, Peng Sun, Yu Wang, Hang Yang, Zhi‐ming Li, Wen‐qi Jiang, Yi Xia
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1845-1851 (2018)
Abstract Primary breast diffuse large B‐cell lymphoma (PB‐DLBCL) is an uncommon extranodal non‐Hodgkin's lymphoma (NHL), which was traditionally treated with anthracycline‐containing regimens followed by consolidative radiation therapy (RT) t
Externí odkaz:
https://doaj.org/article/d9e8b2da38c74639a9394229dd5bdab7
Autor:
Li-Yang Hu, Xiao-Lu Xu, Hui-Lan Rao, Jie Chen, Ren-Chun Lai, Hui-Qiang Huang, Wen-Qi Jiang, Tong-Yu Lin, Zhong-Jun Xia, Qing-Qing Cai
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of T cells and plays a crucial role in the negative regulation of cellular and humoral immune responses. Diffuse large B-cel
Externí odkaz:
https://doaj.org/article/31ade90af9814fb98574f36ebca3d306
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background The prognostic significance of ABO blood type for lymphoma is largely unknown. We evaluated the prognostic role of ABO blood type in patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTL). Methods We retrospectively
Externí odkaz:
https://doaj.org/article/0d2bdca4946744a386341dcf578820fd